A detailed history of Pvg Asset Management Corp transactions in Altimmune, Inc. stock. As of the latest transaction made, Pvg Asset Management Corp holds 23,668 shares of ALT stock, worth $189,344. This represents 0.64% of its overall portfolio holdings.

Number of Shares
23,668
Previous 23,121 2.37%
Holding current value
$189,344
Previous $153,000 5.23%
% of portfolio
0.64%
Previous 0.65%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$5.5 - $8.1 $3,008 - $4,430
547 Added 2.37%
23,668 $145,000
Q2 2024

Aug 22, 2024

BUY
$5.91 - $10.23 $136,645 - $236,527
23,121 New
23,121 $153,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $392M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Pvg Asset Management Corp Portfolio

Follow Pvg Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pvg Asset Management Corp with notifications on news.